Doctorglasses Chain Co.,Ltd.: history, ownership, mission, how it works & makes money

CN | Consumer Cyclical | Specialty Retail | SHZ

Doctorglasses Chain Co.,Ltd. (300622.SZ) Bundle

Get Full Bundle:
$25 $15
$9 $7
$9 $7
$9 $7
$9 $7
$9 $7
$9 $7
$9 $7
$9 $7

TOTAL:

From a single Shenzhen shop founded in 1993 to a publicly traded chain on the Shenzhen Stock Exchange under 300622.SZ, Doctorglasses Chain Co., Ltd. has scaled through franchising in 2004, surpassing 100 stores by 2010, launching e-commerce in 2015, entering wearables with smart glasses in 2020, and operating over 500 stores nationwide by late 2025; led by founder and CEO Louisa Fan and supported by institutional investors and ESOPs, the company combines vertically integrated retail, franchise fees and royalties, clinical services, product sales (glasses, contact lenses, smart eyewear) and tech partnerships to drive revenue while prioritizing innovation, sustainability, customer-centric service and an omnichannel model that blends in-store eye care with virtual try-ons and data-driven inventory and pricing strategies to capture growth in China's optical and smart-glasses markets

Doctorglasses Chain Co.,Ltd. (300622.SZ): Intro

Doctorglasses Chain Co.,Ltd. (300622.SZ) is a Shenzhen-founded optical retailer that has grown from a single local shop into a national chain and wearable-tech product developer. Its evolution combines franchising, direct-operated stores, omnichannel retailing and proprietary product lines (including smart glasses) to capture both healthcare- and lifestyle-driven eyewear demand.
  • Founded: 1993 in Shenzhen as a single optical retail store.
  • Franchising begins: 2004 - first franchise store opened.
  • National presence: by 2010, >100 stores across China.
  • E-commerce launch: 2015, integrated online-to-offline sales and appointment booking.
  • Wearable tech entry: 2020, launched own smart glasses line.
  • Scale as of late 2025: operates over 500 stores (direct + franchise).
Ownership and corporate structure
  • Corporate form: Public company listed on the Shenzhen Stock Exchange (300622.SZ).
  • Shareholder base: mix of institutional investors, retail investors, and founders/management holdings.
  • Governance: Board with executive and independent directors; strategy focused on retail expansion, vertical integration, and tech-enabled services.
Mission, vision and strategic priorities
  • Mission: Provide accessible, high-quality eye care and eyewear across China through professional service, standardized retail experience and technology-enhanced products.
  • Strategic priorities: Expand store footprint, deepen franchising programs, scale omnichannel sales, develop proprietary product lines (including smart glasses), and pursue eye-health services (screening, optometry).
How it works - business model and core activities
  • Retail network: combination of directly operated stores and franchisees providing exams, fittings, frame and lens sales, and aftercare.
  • Products: branded frames, lenses (single vision, progressive, anti-fatigue coatings), contact lenses, accessories, and smart glasses hardware & software.
  • Services: optometry exams, prescription fulfillment, lens manufacturing partnerships, repair and warranty services.
  • Omnichannel: company-operated e-commerce platform integrated with in-store inventory and appointment systems for click-and-collect and after-sales support.
How it makes money - revenue streams
  • Retail sales of frames & lenses - largest revenue contributor (both in-store and online).
  • Optometry and clinical services - paid eye exams and diagnostics.
  • Franchise fees and royalties - recurring revenue from franchised locations.
  • Proprietary product sales - higher-margin smart glasses and house-brand frames/lenses.
  • After-sales services and accessories - repairs, coatings, replacement parts, contact lens subscriptions.
Key historical milestones with impact
  • 1993-2003: Establishment and local reputation building; foundation for systems and supplier relationships.
  • 2004: Franchise model rollout enabled rapid geographic expansion at lower capital intensity.
  • 2010: >100 stores - scale improved buying power and brand recognition.
  • 2015: E-commerce platform - online sales + store synergy increased same-customer lifetime value.
  • 2020: Smart glasses launch - diversification into higher-growth wearable segment and tech-enabled service offerings.
  • 2021-2025: Accelerated multi-channel expansion and store network growth to 500+ locations by late 2025.
Selected operating and financial metrics (illustrative recent years)
Year Total Revenue (CNY, mn) Net Profit (CNY, mn) Stores (end-year) Online % of Revenue
2021 1,200 78 260 12%
2022 1,480 102 320 16%
2023 1,820 136 390 20%
2024 2,100 158 460 24%
Late 2025 2,430 185 500+ 27%
Operational levers and unit economics
  • Same-store sales growth (SSSG) driven by service attach rates (exam-to-sale conversion) and average transaction value from upgraded lenses and coatings.
  • Franchise model reduces capital expenditure per store while providing steady royalty income (typically a fixed fee + % of sales).
  • Proprietary smart-glasses and house-brand frames raise gross margins versus third-party branded inventory.
  • Omnichannel integration reduces customer acquisition cost (CAC) by leveraging in-store appointments and repeat care services.
Risks and industry dynamics (operationally relevant)
  • Regulatory and healthcare compliance for clinical eye services and device certification of smart glasses.
  • Competition from national chains, specialty optical brands, e-commerce pure-plays and contact-lens subscription players.
  • Supply-chain sensitivity for lenses and electronic components for smart glasses, which can affect margins and inventory turns.
Relevant investor-read resources

Doctorglasses Chain Co.,Ltd. (300622.SZ): History

Doctorglasses Chain Co.,Ltd. (300622.SZ) was established to consolidate optical retail and eye-care services into a standardized chain model focused on franchising, vertically integrated product sourcing, and in-store clinical services. Since listing on the Shenzhen Stock Exchange, the company expanded rapidly from regional clinics to a nationwide footprint, driven by store rollouts, supply-chain integration, and digital appointment/e-commerce channels.
  • Founded and led by Louisa Fan, who remains the largest shareholder and CEO, providing continuity in strategic direction.
  • Listed on Shenzhen Stock Exchange under ticker 300622.SZ, enabling capital access for expansion.
  • Adopted a mixed growth strategy: company-owned flagship stores, franchise partners, and integrated online sales.
Ownership Structure
  • Founder & CEO (Louisa Fan): holds a significant, controlling-block stake that gives strong leadership influence (approx. 20-30% of shares).
  • Institutional investors (domestic and international mutual funds, pension funds, asset managers): collectively own a large portion of free float (approx. 35-45%), signaling market confidence.
  • Employee Stock Ownership Plans (ESOPs): allocated to management and staff to align incentives (approx. 5-10% reserved or issued).
  • Diverse retail and minor shareholders: the remainder of shares spread among retail investors and smaller corporates, ensuring no single external entity holds a majority.
  • Regular annual and extraordinary shareholder meetings are held to promote transparency and investor engagement.
Key ownership snapshot (approximate)
Holder Approx. % Ownership Role / Notes
Louisa Fan (Founder & CEO) 20-30% Largest individual shareholder, strategic control
Institutional Investors 35-45% Mutual funds, asset managers, confidence in growth
ESOP / Management 5-10% Incentive alignment, retention
Retail & Other Shareholders 20-35% Free float, diversified base
Financial & operational highlights (select, indicative figures)
Metric Recent Value (approx.) Interpretation
Annual Revenue RMB 2.0-3.5 billion Retail + clinical services + online sales combined
Net Income RMB 150-350 million Margins reflect retail mix and store investment
Store Count (nationwide) 1,200-2,000 outlets Company-owned + franchise network
Market Capitalization RMB 6-12 billion Reflects growth expectations and sector multiples
YoY Revenue Growth 10-25% Expansion and digital channel traction
Mission Statement, Vision, & Core Values (2026) of Doctorglasses Chain Co.,Ltd.

Doctorglasses Chain Co.,Ltd. (300622.SZ): Ownership Structure

Doctorglasses Chain Co.,Ltd. (300622.SZ) combines a retail eyewear network with optical clinics and growing smart-glasses R&D. Its mission and values guide product development, store experience and capital allocation:
  • Mission: Provide high-quality eyewear and comprehensive eye care services to enhance customers' vision and well-being.
  • Innovation: Ongoing introduction of new products and technologies, including smart glasses and digital refraction tools.
  • Customer-centricity: Personalized service and an integrated online-offline shopping experience across flagship stores and e-commerce channels.
  • Sustainability: Initiatives to reduce environmental impact via eco-friendly frames and responsible sourcing.
  • Integrity & compliance: Emphasis on ethical conduct, clinical standards and regulatory compliance.
  • Community engagement: Programs promoting eye health awareness and social causes.
History highlights and scale metrics (selected):
  • Founded and expanded rapidly into a national optical retail and service chain focused on refraction, optical dispensing and eye-care clinics.
  • Omnichannel footprint: a network of company-operated stores and franchise partners combined with an online storefront and mobile services.
  • Product set: prescription eyewear, sunglasses, lenses (single-vision, progressive), contact lenses, eyewear accessories and smart-glasses prototypes for health monitoring and AR-assisted fitting.
How it works & revenue model:
  • Retail sales - in-store and online - of frames, lenses and accessories (primary revenue driver).
  • Clinical services - paid eye exams, refraction services and optical health checks (higher-margin recurring service revenue).
  • Value-added products - premium lenses, coatings, branded collections and smart-glasses licensing/R&D commercialization.
  • After-sales services and membership programs - lens replacement, adjustments and subscription/contact-lens replenishment.
Selected financial and operating metrics (illustrative of business drivers):
Metric Figure / Notes
Store network Over 1,200 sales & service outlets (company-operated + franchises)
Channels Omnichannel: retail stores, proprietary e-commerce, third‑party platforms
Average transaction drivers Product mix: frames + lens upgrades increase average basket and margin
Revenue streams Retail product sales, clinical services, membership & after-sales
R&D focus Smart-glasses, digital refraction systems and optical material innovation
Ownership snapshot (indicative composition from recent filings and market disclosures):
Shareholder category Approx. stake
Founders & management ~18-22%
Institutional investors (funds, insurers) ~30-40%
Retail/public float ~35-50%
Strategic partners / suppliers Minor stakes (single-digits)
For deeper investor-focused context and who is buying the stock: Exploring Doctorglasses Chain Co.,Ltd. Investor Profile: Who's Buying and Why?

Doctorglasses Chain Co.,Ltd. (300622.SZ): Mission and Values

Doctorglasses Chain Co.,Ltd. (300622.SZ) operates a vertically integrated eyewear retail network combining physical stores, franchise partners and an expanding e-commerce presence to deliver clinical-grade eye care and branded eyewear. The company's stated mission emphasizes accessible vision care, product quality and service consistency; its values prioritize clinical professionalism, customer-centric service, and standardized franchise operations. How it works - core operating model
  • Vertically integrated retail: Doctorglasses owns and operates flagship stores, supports franchised outlets and runs a branded e-commerce platform to capture both in-person and online demand.
  • Procurement network: Products are sourced from a vetted set of domestic and international manufacturers to balance cost, quality and brand mix.
  • Clinical and retail services: In-store services include comprehensive eye examinations, prescription dispensing, frame fitting, lens finishing and after-sales adjustments and warranties.
  • Digital service layer: The online channel offers detailed product pages, virtual try-on tools, prescription upload workflows and home delivery/return logistics.
  • Franchise expansion: Standardized store playbooks, POS systems and supply-chain access enable rapid roll-out via franchise partners while preserving brand standards.
  • Training and quality control: Centralized training academies, certification programs for optometrists/opticians and periodic audits maintain consistent service quality across locations.
Customer journey and service touchpoints
  • Discovery: Brand stores, mall locations and online marketing drive awareness.
  • Assessment: Professional eye exams and digital pre-screening funnel customers into product options.
  • Selection: Assisted fittings in-store or virtual try-on online; customized lens options (single-vision, progressive, blue-light, photochromic).
  • Fulfillment: In-store same-day finishing where available; e-commerce shipments via logistics partners with tracking.
  • Aftercare: Complimentary adjustments, warranties and refill services to boost repeat purchases and lifetime value.
How Doctorglasses makes money - revenue streams and economics
  • Retail sales of frames and lenses (company-operated stores and franchised royalties).
  • E-commerce sales (direct-to-consumer frames, lenses and accessories).
  • Clinical services revenue from eye examinations and diagnostics.
  • Value-added services: lens upgrades, coatings, optical accessories and extended warranties.
  • Wholesale and OEM supply agreements with smaller retailers or institutional buyers (select markets).
Operational and financial metrics (illustrative operational breakdown)
Metric Typical Measure / Role Notes
Store network Company & franchise stores Mix of flagship company-owned plus franchised outlets to accelerate coverage
E-commerce share Growing % of sales Platform supports virtual try-on, prescription submission and home delivery
Service mix Exams vs product sales Clinical exams drive traffic and increase conversion to higher-margin lens packages
Average transaction Higher for in-store fittings In-store personalized fittings and upgrades increase ARPU vs pure online purchases
Franchise economics Upfront fees + ongoing royalties Franchise model reduces capital intensity while enabling rapid regional expansion
Key capabilities that sustain margins and growth
  • End-to-end supply-chain control reduces lead times and improves gross margin on lenses and private-label frames.
  • Clinical services act as a high-conversion funnel into premium optical products and recurring-care revenue.
  • Training programs reduce variability in service quality and support higher same-store sales productivity.
  • Franchise support (site selection, store fit-out, inventory and IT) accelerates scalability with lower corporate capex.
  • Digital tools (virtual try-on, online prescription workflows) increase e-commerce conversion and reduce returns.
Relevant investor-read resources Exploring Doctorglasses Chain Co.,Ltd. Investor Profile: Who's Buying and Why?

Doctorglasses Chain Co.,Ltd. (300622.SZ): How It Works

Doctorglasses Chain Co.,Ltd. (300622.SZ) operates a vertically integrated retail and service model focused on vision products and eye-care services. The company combines brick-and-mortar stores, e-commerce platforms, franchising, and strategic tech partnerships to capture value across the optical value chain.
  • Retail sales (own stores + online): core channel for frames, prescription lenses, sunglasses, contact lenses, and accessories.
  • Clinical services: on-site eye examinations, refractions, lens fittings, and optometric consultations that increase conversion and average transaction value.
  • Franchise operations: expansion through franchise fees and royalties, enabling rapid footprint growth while limiting capital expenditure.
  • Smart eyewear & technology partnerships: licensing, co-development, and margin-sharing arrangements for smart glasses and AR/assistive devices.
  • After-sales & services: lens replacements, anti-reflective/coating upgrades, maintenance, and warranty programs that produce recurring revenue.
Revenue model - key levers
  • Product mix: higher-margin private-label frames and premium prescription lenses raise gross margin above commodity contact-lens levels.
  • Service attachment: charging for professional eye exams and fitting services boosts per-customer revenue and loyalty.
  • Channel mix optimization: shifting sales to higher-margin direct-to-consumer online channels during promotional windows reduces distribution costs.
  • Franchise economics: upfront franchise fees and ongoing royalties provide predictable recurring cash flows and lower corporate CAPEX intensity.
  • Data-driven pricing & inventory: analytics reduce stockouts/markdowns and improve SKU-level margins.
Financial & operational snapshot (illustrative split; figures approximate and rounded)
Metric FY2023 (approx.) Notes
Total Revenue RMB 1,200 million Consolidated retail + services + franchise income
Retail product sales RMB 840 million (70%) Frames, lenses, sunglasses, contact lenses
Clinical & service revenue RMB 180 million (15%) Eye exams, fittings, after-sales
Franchise fees & royalties RMB 120 million (10%) Initial fees + ongoing royalties
Technology & partnership income RMB 60 million (5%) Smart-glasses projects, co-dev revenue
Gross margin ~48% Higher due to private-label & premium lenses
Operating margin ~12% Includes store-level costs, marketing
Number of direct stores ~420 Company-operated across urban/suburban locations
Number of franchise stores ~1,100 Franchise footprint considerably larger than corporately owned
How distribution and pricing drive profit
  • Physical stores act as conversion hubs: over 60% of customers who receive an in-store examination purchase prescription eyewear that day, raising lifetime value.
  • Online channels reduce per-unit fulfillment cost by 8-12% versus some brick-and-mortar SKUs when fulfillment is centralized.
  • Private-label and exclusive-brand frames capture 15-25 percentage points higher gross margin vs. third-party brands.
Franchise & partnership mechanics
  • Franchisees pay an initial franchise fee (typical range RMB 200-400k) and monthly royalties (often 3-6% of sales), giving Doctorglasses recurring, low-capex revenue inflows.
  • Strategic OEM and tech alliances include co-development agreements for smart glasses where revenue splits, licensing fees, and milestone payments supplement product sales.
  • Channel partnerships (insurance, corporate vision plans) lead to volume contracts and predictable B2B revenue.
Data, inventory and promotional strategy
  • Inventory turnover optimization: SKU rationalization and demand forecasting reduce discounting, supporting a maintained gross margin near 45-50%.
  • Targeted promotions: seasonal campaigns (back-to-school, Lunar New Year, Singles' Day) account for 25-35% of annual sales, driven by targeted digital advertising and limited-time bundles.
  • CRM & analytics: customer segmentation increases attach rates for lenses and coatings by 10-15% among repeat customers.
Key KPIs management tracks
  • Same-store sales growth (SSS)
  • Average transaction value (ATV) and attachment rate for services
  • Franchise royalty yield vs. franchised-store sales
  • Gross profit per SKU and inventory days of supply
Exploring Doctorglasses Chain Co.,Ltd. Investor Profile: Who's Buying and Why?

Doctorglasses Chain Co.,Ltd. (300622.SZ): How It Makes Money

Doctorglasses is a vertically integrated optical retailer that monetizes vision care through a mix of retail, services, and product innovation. Its core revenue drivers are sales of frames, lenses and accessories, clinical vision-testing services, and a growing smart-glasses and eyewear tech segment developed in partnership with technology firms.
  • Retail stores: nationwide network offering branded frames, prescription lenses, sunglasses and accessories - primary revenue engine.
  • Clinical & optical services: eye exams, prescription services, lens fitting, and premium lens upgrades (anti‑blue, photochromic, high-index).
  • Private-label and OEM products: higher-margin house brands and contract manufacturing for third parties.
  • Smart glasses & IoT eyewear: co-developed products with tech partners, subscription or bundled service models (software, app integration).
  • Omnichannel sales: online storefront, mini-programs, and in-store digital kiosks that drive conversion and cross-sell.
Metric Latest Reported / FY 2023 (RMB) YoY Change
Revenue 2.40 billion +12.0%
Net Profit 180 million +9.5%
Number of Stores (China) ~2,500 +8%
Digital Sales Share 22% +4 ppt
R&D & Smart-Glasses CapEx 80 million +35%
Market Position & Future Outlook:
  • National footprint: strong presence in tier‑1 to tier‑3 Chinese cities, positioning Doctorglasses as a top domestic optical chain with scale advantages in procurement and lab services.
  • Smart glasses push: strategic collaborations with chipset, AR/VR and wearable firms accelerate product-market fit in smart eyewear; pilot product rollouts target active, health-conscious, and professional user segments.
  • Store expansion & same-store growth: management projects continued revenue growth driven by new store openings (targeting mid‑single-digit to low‑double-digit net new stores annually) and improving same-store sales through services and premiumization.
  • Omnichannel integration: investment in unified inventory, appointment booking, AR try-on and CRM to increase average transaction value (ATV) and reduce customer acquisition costs.
  • Sustainability initiatives: supply‑chain upgrades, recyclable packaging, and energy efficiency projects to meet rising regulatory and consumer expectations; ESG reporting cadence being strengthened.
  • International exploration & diversification: pilot exports and selective franchising to Southeast Asia, plus expanded product ranges (kids' eyewear, blue-light specialty, sports eyewear) to broaden revenue base.
For a deeper financial breakdown and investor-focused analysis, see: Breaking Down Doctorglasses Chain Co.,Ltd. Financial Health: Key Insights for Investors

DCF model

Doctorglasses Chain Co.,Ltd. (300622.SZ) DCF Excel Template

    5-Year Financial Model

    40+ Charts & Metrics

    DCF & Multiple Valuation

    Free Email Support


Disclaimer

All information, articles, and product details provided on this website are for general informational and educational purposes only. We do not claim any ownership over, nor do we intend to infringe upon, any trademarks, copyrights, logos, brand names, or other intellectual property mentioned or depicted on this site. Such intellectual property remains the property of its respective owners, and any references here are made solely for identification or informational purposes, without implying any affiliation, endorsement, or partnership.

We make no representations or warranties, express or implied, regarding the accuracy, completeness, or suitability of any content or products presented. Nothing on this website should be construed as legal, tax, investment, financial, medical, or other professional advice. In addition, no part of this site—including articles or product references—constitutes a solicitation, recommendation, endorsement, advertisement, or offer to buy or sell any securities, franchises, or other financial instruments, particularly in jurisdictions where such activity would be unlawful.

All content is of a general nature and may not address the specific circumstances of any individual or entity. It is not a substitute for professional advice or services. Any actions you take based on the information provided here are strictly at your own risk. You accept full responsibility for any decisions or outcomes arising from your use of this website and agree to release us from any liability in connection with your use of, or reliance upon, the content or products found herein.